acyclovir

NDC 70954-188 · ANI Pharmaceuticals, Inc.

Generic nameacyclovir

Dosage formSUSPENSION

RouteORAL

Active ingredient(s)ACYCLOVIR

Strength200 mg/5mL

Pharmacologic classDNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]

Marketing categoryANDA

Packages

70954-188-10 — 473 mL in 1 BOTTLE (70954-188-10)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70518-2117 — Acyclovir, 70518-2455 — Acyclovir, 70518-2518 — Acyclovir, 70518-3436 — acyclovir, 70518-4186 — ACYCLOVIR, 70518-4414 — Acyclovir, 70518-4450 — Acyclovir, 70700-107 — Acyclovir, 70771-1371 — acyclovir, 70771-1808 — Acyclovir, 71205-053 — Acyclovir, 71205-056 — Acyclovir, 71205-209 — Acyclovir, 71205-243 — ACYCLOVIR, 71205-371 — ACYCLOVIR, 71205-388 — ACYCLOVIR, 71205-391 — acyclovir, 71205-472 — Acyclovir, 71205-578 — Acyclovir, 71209-004 — Acyclovir, +172 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels